SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is surging following conditional marketing authorization from the European Commission for ANKTIVA + BCG in BCG-unresponsive bladder cancer, expanding its market to 33 countries and fueling strong community speculation about a significant short squeeze.

Starfighters Space, Inc. is engaged in the research and development of space flight, pilot training, and aeronautics programs. It operates the commercial fleet Lockhead F-104s. The company was founded by Rick Svetkoff on September 6, 2022 and is headquartered in Cape Canaveral, FL.

Starfighters Space Inc

Starfighters Space Inc. ($FJET) is trending amidst high short-squeeze speculation, fueled by its extremely low float and substantial insider ownership, with the community actively debating its potential for massive gains. This excitement is further amplified by anticipation that the upcoming Space X IPO will drive the entire space sector, though some caution remains regarding the viability of air-launched small satellite ventures.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending lower after providing a weaker profit outlook, despite exceeding revenue estimates and demonstrating strong billings growth. Investors are fiercely debating whether the drop is an overreaction to short-term acquisition costs and AI disruption fears, or a sign of deeper issues for the cybersecurity giant.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community eagerly awaits the anticipated BLA resubmission for Deramiocel, following overwhelmingly positive Phase 3 HOPE-3 data. Investors are bullish on accelerated FDA approval and growing institutional interest, despite short-term market fluctuations and broader concerns around regulatory hurdles.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

Hycroft Mining Holding Corp

Hycroft Mining is trending with intense community discussion and bullish sentiment driven by a recent update signaling significant growth in its mineral resources, alongside notable institutional interest, and speculation about a short squeeze fueled by broader appreciation in precious metal prices.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Activist investor Nelson Peltz's Trian Fund Management is actively reviewing its stake in Wendy's, exploring options including a potential acquisition or other control-gaining transactions, citing the stock's undervaluation. This development is sparking intense community discussion about a potential short squeeze and a significant rebound for the quick-service restaurant chain, which many believe is deeply undervalued amidst its appealing dividend yield.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera Inc. is trending on surging volume and community excitement following revelations from its recent earnings call regarding significant breakthroughs in Gate-All-Around (GAA) and GaN-on-Silicon technologies. Investors are anticipating imminent licensing agreements with major chipmakers like TSMC or Samsung, driven by Atomera's Mears Silicon Technology (MST) offering crucial power efficiency improvements for AI and data center applications, amid speculation of institutional accumulation and a potential short squeeze.

WorldFinancial

WorldFinancial (WLFI) is trending amidst an upcoming Mar-a-Lago forum, where potential institutional adoption and new platform launches are anticipated, while simultaneously facing intense scrutiny from a Congressional probe into its foreign investment ties. This has ignited a fierce debate within the community, split between bullish conviction in its disruptive potential and strong bearish sentiment labeling it a pump-and-dump amid regulatory concerns.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

IMG CRYPTO is trending as its diamond-handed community celebrates its 1-year anniversary, highlighting its unique 'Infinite Money Glitch' model that consistently distributes passive Solana rewards, alongside anticipation for new technological developments and increased volume.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is trending as a major institutional investor significantly increased its stake by repurchasing shares at much higher prices, igniting community discussions about the stock's deep undervaluation, potential for a short squeeze, and heightened anticipation for its upcoming Investor Day, which is expected to deliver crucial clinical data updates and regulatory strategy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Delcath Systems to Host Fourth Quarter and Full Year 2025 Earnings Call

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today it will host a conference call on...

Delcath Systems, Inc. (NASDAQ:DCTH) Given Average Recommendation of "Moderate Buy" by Analysts

Delcath Systems, Inc. (NASDAQ:DCTH - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six brokerages that are covering the company, MarketBeat reports. One equities research...

Delcath Systems to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced that management will be attending the...

Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Delcath Systems, Inc. (Nasdaq: DCTH) (the Company or Delcath), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company...

Are Options Traders Betting on a Big Move in Delcath Systems Stock?

Investors need to pay close attention to DCTH stock based on the movements in the options market lately. 

Simplify Asset Management Inc. Increases Stock Position in Delcath Systems, Inc. $DCTH

Simplify Asset Management Inc. increased its holdings in Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) by 144.9% during the third quarter, according to its most recent filing with the Securities...

Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Recommendation of "Moderate Buy" by Analysts

Delcath Systems, Inc. (NASDAQ:DCTH - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the six analysts that are covering the company, Marketbeat reports. One investment...

Vivo Capital LLC Decreases Stake in Delcath Systems, Inc. $DCTH

Vivo Capital LLC cut its stake in shares of Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) by 24.1% during the second quarter, according to the company in its most recent filing with the...

Delcath Systems, Inc. $DCTH Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC boosted its holdings in Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) by 128.1% during the second quarter, according to its most recent Form 13F filing with the SEC...

Do Options Traders Know Something About Delcath Systems Stock We Don't?

Investors need to pay close attention to Delcath Systems stock based on the movements in the options market lately.

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Delcath Systems Inc

Fundamental

Technical

A mix of both

Some investors focus on company fundamentals like earnings, growth, and valuation. Others rely on price action, trends, and momentum. Many use a combination of both to guide their decisions. What do you use?

What type of analysis drives your investment decisions?

DCTH
Delcath Systems Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest DCTH News

DCTHDelcath Systems Inc